The market estimates provided by your team were pretty much in line with what we were theorizing internally. We recently commissioned multiple market research reports from IMARC, and the insights we received were invaluable. The detailed insights and actionable data have consistently provided us with a competitive edge in a rapidly changing alcohol market. The market reports from IMARC have been instrumental in guiding our business strategies. We would be happy to reach out to IMARC for more market reports in the future.
Circumvent The Tariff Challenges With An Agile Supply Chain Consulting
However, there has been a rise in the number of generic drug manufacturers, who are able to offer cheaper alternatives to branded drugs. The market Anti-Rheumatic Drugs includes pharmaceuticals specifically developed to alleviate symptoms, reduce inflammation, and modify the progression of rheumatic diseases. The Pharmaceuticals market is organized in markets that cover drugs used in specific medical fields, i.e., medicines for a specific disesase or a certain type of medicine. The current North American system of interventional silos between specialities must be abandoned to be able to respond to future drug market shifts and their potentially detrimental public health impact. Until now, these exports had little impact on Australian drug markets which is probably owed to the diligent work of Australian border control forces .
The over-the-counter (OTC) segment is expected to grow at the highest CAGR during the forecast period. Governments worldwide have implemented favorable reimbursement policies for prescribed medication, bolstering the segment growth. The U.S.'s Inflation Reduction Act (IRA) is projected to decrease 31% of U.S. pharmaceutical companies' revenue by 2039.
Based on formulation, the global market is segmented into tablets, capsules, injectable, sprays, suspension and powder. OTC medicines, which are available without a prescription, allow people to treat common illnesses and health problems on their own, which is benefiting the market growth. Moreover, the rising hospitalization and prescription rates are factors that further drive the growth of the overall pharmaceutical industry. Hence, major pharmaceutical companies are involved in clinical trials for the development and ultimately approval of new products.
Prescription Drug Statistics – Trends In Usage
The utilization of these lower-cost medications resulted in substantial cost savings amounting to $373 billion for various stakeholders, including patients, consumers, employers, and taxpayers. Hospital pharmacies contain all the medicines that are prescribed by healthcare professionals. The increasing number of retail pharmacies allow people to buy medicines from their vicinity. It eliminates the chances of drug metabolism by liver or gastrointestinal routes.
The Pharmaceutical Industry: A Key Asset To The European Economy
The global generic drug market is a fiercely competitive arena dominated by a handful of multinational titans, a dynamic cohort of specialized players, and a vast number of smaller regional manufacturers. The global generic drug market is not a monolithic entity but a complex mosaic of distinct regional and national markets, each shaped by its own unique regulatory frameworks, reimbursement systems, competitive dynamics, and cultural attitudes. This high-cost, high-risk environment limits the field of competitors to a handful of large, well-capitalized companies, effectively creating a high-value “market within a market” where the dynamics more closely resemble the innovative pharmaceutical sector than the traditional generics space. Despite the strong growth drivers, the generic drug market is fraught with significant challenges that test the resilience and strategic acumen of even the most established players. The single most significant driver of the generic drug market is the cyclical expiration of patents on blockbuster brand-name drugs.
Discover how Mercer Government’s Managed Pharmacy practice helps state Medicaid programs tackle the challenges of cost management and access to care. Outside of pharmacy trend, new gene therapies and wider acceptance of existing products will further increase drug spend. While biosimilars could represent meaningful decreases in pharmacy costs, the extent will depend on coverage policies, patient and provider acceptance, and product availability. Trend projections for 2025–2026 are comparable to 2024–2025, despite several expensive new products for rare diseases. Information related to the drug pipeline, clinical guidelines, and post-pandemic experience is rapidly evolving, and we continue to evaluate and adjust pharmacy trend projections as needed throughout the year.
What Is The Expected Growth Rate Of Global Prescription Drugs Market?
This protects its drug research investment by giving the pharmaceutical company the sole right to manufacture and sell the branded drug while the patent is in effect. With advancements in biotechnology, personalized medicine, and artificial intelligence in drug discovery, the pharmaceutical sector continues to evolve rapidly. This industry plays a crucial role in global healthcare by improving life expectancy and quality of life. Moreover, extending the reach of supply chains and improving overall efficiency are also some of the essential components of growth strategies that work well in emerging markets. Additionally, digital transformation, AI-driven drug discovery, and telemedicine integration are further fueling market expansion.
The Next Decade: Key Trends Defining The Future Market
This mixing of substances can lead to the development of multiple concurrent substance use disorders and even complicate overdose management (i.e., different antagonists are required to treat benzodiazepine and opioid overdoses). Health care systems across the North American continent have so far been unable to effectively respond to the continuously increasing overdose mortality rates . For example, organised crime groups exercise significant control of the drug trade in some larger US cities and are unlikely to tolerate competition from local producers. Following China’s announcement to control fentanyl in 2019, several local drug laboratories emerged in Mexico and other North American metropolitan areas . This has previously been referred to as the ‘Iron Law of Prohibition’, whereby pressures due to attempted interruption and suppression of the illicit drug supply leads to ever-more compact substitutes .
Besides, these companies engage in strategic partnerships, collaborations, and licensing agreements to enhance their product portfolios and expand market reach. Furthermore, these companies maintain strong manufacturing capabilities and efficient supply chains, ensuring a steady and reliable supply of generic medications. They focus on developing cost-effective alternatives to brand-name medications across various therapy areas, addressing the needs of patients and healthcare providers for affordable treatment options. Hospitals can leverage their purchasing power to negotiate favorable pricing agreements with generic drug manufacturers.
Pharmaceutical drug refers to a substance created to treat, prevent, or cure an illness or other condition, or to lessen its symptoms. As a content reviewer, Aditi plays a critical role in ensuring the quality and accuracy of all market insights and data presented by the research team. Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. In general, leaders stressed the need for creative leadership to adopt new pharmaceutical advances and develop mechanisms that would guarantee the accessibility and affordability of upcoming therapies. A large population visits hospitals for disease treatment, during which a lot of pharmaceuticals are used in the hospital. This group is the largest and consumes various pharmaceutical products for better health and to improve quality of life.
Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. Leaders urged CEOs to use new AI technologies, pointing out that recent developments in AI might significantly affect pharmaceutical research and innovation. By formulation, the sprays segment is expected to grow at the fastest rate during the forecast period. They have a stronger impact than oral drugs because they are digested differently and do not go through the digestive processes in the gastrointestinal tract. By route of administration, the oral segment secured the largest share of the market in 2023.
The online pharmacies segment is anticipated to grow at the highest CAGR over the forecast period, especially due to the ease provided to patients in the refilling of prescription medications and the ability to acquire drugs from the comfort of their homes. The other segment contains critical and life-saving drugs such as oncology, anti-diabetic and cardiovascular drugs and has been instrumental in the dominance of this segment in the global market. Hence, the other prescription drugs segment dominated the market share in 2023. In addition, the governments of different nations are introducing different schemes to provide generic drugs at a lower cost than their branded equivalents. These factors also limited the number of patient visits to hospitals, and the dispersion of prescriptions by healthcare professionals, further moderately limiting the demand and adoption of prescription drugs. Moreover, the U.S. prescription drugs market size is projected to grow significantly, reaching an estimated value of USD 931.1 million by 2032, driven by rising approval of orphan drugs by regulatory agencies.
- Between 2025 and 2030, the industry is set to witness one of the largest waves of patent expiries in history, with estimates suggesting that branded drugs generating between $217 billion and $236 billion in annual sales will lose their market exclusivity.2
- These pharmaceutical products diagnose, treat, and prevent chronic diseases such as cancer, diabetes, and genetic disorders.
- Moreover, dermatology includes treatments for skin conditions like acne, eczema, and psoriasis, the availability of generic medications offers cost-effective solutions.
- This led to the increased collaboration between major Colombian and Mexican drug traffickers.
Subscribe To Our Exclusive Market Insights
Equally, recently implemented strategies like the “safer supply” of drugs has had no impact on the development so far 64, 65. Equally, purely legislative measures like prohibition and prosecution of substance possession and personal use have so far also been unsuccessful in stopping the flourishing drug market and reducing the mortality rate in North America. An undisputable contributing factor to this overdose crisis is prescription opioids, which were widely available at the turn of the century and coupled with insufficient regulation of the pharmaceutical and healthcare industries .
What Are The Effects Of Emerging Drugs?
The corresponding regulatory agencies approve these generics in the country where they are marketed. These drugs contain different excipients, colors, and flavors to distinguish them from the original ones. Generic medicines also don’t require much R&D, which reduces the overall production and development costs. By examining high volumes of biomedical data, finding possible therapeutic targets, and forecasting the efficiency of drug candidates, artificial intelligence (AI) algorithms can speed up the drug discovery process. A key goal of drug discovery campaigns is the recognition of new molecular entities that may be of value in the treatment of diseases that qualify as presenting unmet medical needs.
U.S. Pharmaceutical market, 2018 – 2033 (USD MILLION)12.2.3. North America Pharmaceutical market, 2018 – 2033 (USD Million)12.2.2. Rising chronic diseases and geriatric population3.2.2. The clinic segment is expected to grow the fastest, driven by its role in preventive care, early diagnosis, and managing common illnesses.
A Brief History: From Policy Catalyst To Global Juggernaut
Whereas, the rising middle class in Mexico is achieving a raised disposable income, which influences demand for healthcare, including pharmaceuticals. Along with this, the national health services (NHS) enable a vast and stable market for pharmaceutical products, ultimately assisting market growth. The robust healthcare system of Germany is widely emphasizing the quality and safety of the patient, which demands a range of pharmaceutical products. As well as, Europe is approaching various pharmaceutical companies to make collaborations and enhance the R&D, which results in novel drug discovery. Government is supporting with its policies, such as the Production-Linked Incentive (PLI) scheme, bulk drug parks, and the National R&D Policy are also propelling demand for the drugs.
GSK plc acquired clinical-stage biopharmaceutical company Affinivax, Inc. in May 2022 to strengthen its vaccine R&D pipeline, gain access to new technologies, and expand its geographic reach in the Boston area. In the LAMEA region, which comprises nations like Argentina, Brazil, Mexico, the United Arab Emirates, Saudi Arabia, Africa, and others the pharmaceutical sector has expanded dramatically. Furthermore, during the projected period, higher sales of medications and vaccines for chronic illnesses are also anticipated to fuel the growth. Drugs with an unpleasant taste should preferably be formulated as a suspension to reduce the interaction of the drug with the taste receptors in the mouth. Once the active pharmaceutical ingredients (API) are mixed into a spray concentrate, they are pumped into the sprayer, which atomizes it during administration.
